ZBH logo

Zimmer Biomet Holdings (ZBH) Accounts Receivable

Annual Accounts Receivable

$1.44 B
+$60.90 M+4.41%

December 31, 2023

Summary

Performance

1-Year Change

+4.41%

3-Year Change

-0.71%

5-Year Change

+13.06%

15-Year Change

-6.59%

ZBH Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

94%
ZBH annual accounts receivable is higher than 94% of companies in Healthcare sector

High & Low

All-time High

$1.60 B
ZBH annual accounts receivable is currently -10.10% below its historical high of $1.60 billion

3-Year Low

$1.26 B
ZBH annual accounts receivable is currently +14.51% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ZBH previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ZBH next annual earnings announcement has not yet been scheduled

OtherZBHbalance sheetmetrics:

Annual Accounts Payable

$410.60 M
ZBH annual accounts payable is $410.60 million

Annual Total Assets

$21.50 B
ZBH annual total assets is $21.50 billion

Annual Total Liabilities

$9.01 B
ZBH annual total liabilities is $9.01 billion

Annual Cash & Cash Equivalents

$415.80 M
ZBH annual cash & cash equivalents is $415.80 million

Quarterly Accounts Receivable

$1.48 B
+$63.50 M+4.48%

September 30, 2024

Summary

Performance

3-Month Change

+4.48%

1-Year Change

+2.71%

3-Year Change

+15.88%

5-Year Change

+4.3%

ZBH Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

94.45%
ZBH quarterly accounts receivable is higher than 94.45% of companies in Healthcare sector

High & Low

All-time High

$1.60 B
ZBH quarterly accounts receivable is currently -7.66% below its historical high of $1.60 billion

3-Year Low

$1.25 B
ZBH quarterly accounts receivable is currently +18.12% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ZBH previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
ZBH next earnings announcement has not yet been scheduled

OtherZBHbalance sheetmetrics:

Quarterly Accounts Payable

$322.40 M
ZBH quarterly accounts payable is $322.40 million

Quarterly Total Assets

$21.72 B
ZBH quarterly total assets is $21.72 billion

Quarterly Total Liabilities

$9.34 B
ZBH quarterly total liabilities is $9.34 billion

Quarterly Cash And Cash Equivalents

$569.00 M
ZBH quarterly cash and cash equivalents is $569.00 million

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

ZBH Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.4%+2.7%
3 y3 years-0.7%+15.9%
5 y5 years+13.1%+4.3%

ZBH Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+14.5%at high+18.1%
5 y5-year-0.7%+14.5%at high+42.6%
alltimeall time-10.1%+693.8%-7.7%+715.4%

Zimmer Biomet Holdings Accounts Receivable History

DateAnnualQuarterly
Sep 2024
-
$1.48 B(+4.5%)
Jun 2024
-
$1.42 B(-2.0%)
Mar 2024
-
$1.45 B(+0.3%)
Dec 2023
$1.44 B(+4.4%)
$1.44 B(+7.6%)
Sep 2023
-
$1.34 B(-1.9%)
Jun 2023
-
$1.37 B(-1.0%)
Mar 2023
-
$1.38 B(-0.0%)
Dec 2022
$1.38 B(+9.7%)
$1.38 B(+8.1%)
Sep 2022
-
$1.28 B(-0.3%)
Jun 2022
-
$1.28 B(+2.2%)
Mar 2022
-
$1.25 B(-0.4%)
Dec 2021
$1.26 B(-13.3%)
$1.26 B(-9.5%)
Sep 2021
-
$1.39 B(-2.0%)
Jun 2021
-
$1.42 B(+2.9%)
Mar 2021
-
$1.38 B(-5.0%)
Dec 2020
$1.45 B(+6.5%)
$1.45 B(+8.4%)
Sep 2020
-
$1.34 B(+25.9%)
Jun 2020
-
$1.06 B(+2.4%)
Mar 2020
-
$1.04 B(-23.8%)
Dec 2019
$1.36 B(+6.9%)
$1.36 B(+18.5%)
Sep 2019
-
$1.15 B(-7.7%)
Jun 2019
-
$1.25 B(+1.8%)
Mar 2019
-
$1.23 B(-4.0%)
Dec 2018
$1.28 B(-17.4%)
$1.28 B(+1.0%)
Sep 2018
-
$1.26 B(-5.4%)
Jun 2018
-
$1.34 B(-5.9%)
Mar 2018
-
$1.42 B(-8.1%)
Dec 2017
$1.54 B(-3.8%)
$1.54 B(+17.1%)
Sep 2017
-
$1.32 B(-7.3%)
Jun 2017
-
$1.42 B(-11.1%)
Mar 2017
-
$1.60 B(-0.3%)
Dec 2016
$1.60 B(+10.9%)
$1.60 B(+0.0%)
Sep 2016
-
$1.60 B(+0.6%)
Jun 2016
-
$1.59 B(+1.6%)
Mar 2016
-
$1.57 B(+8.4%)
Dec 2015
$1.45 B(+58.6%)
$1.45 B(+4.4%)
Sep 2015
-
$1.39 B(-7.1%)
Jun 2015
-
$1.49 B(+71.3%)
Mar 2015
-
$869.80 M(-4.6%)
Dec 2014
$912.10 M(-2.6%)
$912.10 M(-3.7%)
Sep 2014
-
$947.60 M(-0.3%)
Jun 2014
-
$950.20 M(+1.2%)
Mar 2014
-
$939.10 M(+0.3%)
Dec 2013
$936.60 M
$936.60 M(+4.2%)
Sep 2013
-
$898.90 M(-4.6%)
Jun 2013
-
$942.50 M(+3.3%)
DateAnnualQuarterly
Mar 2013
-
$912.50 M(+3.2%)
Dec 2012
$884.60 M(+5.5%)
$884.60 M(+1.1%)
Sep 2012
-
$874.90 M(-3.5%)
Jun 2012
-
$906.70 M(+1.3%)
Mar 2012
-
$895.00 M(+6.7%)
Dec 2011
$838.80 M(+8.1%)
$838.80 M(+1.3%)
Sep 2011
-
$827.90 M(-6.8%)
Jun 2011
-
$888.40 M(+1.4%)
Mar 2011
-
$876.30 M(+12.9%)
Dec 2010
$775.90 M(+3.3%)
$775.90 M(+1.4%)
Jun 2010
-
$765.10 M(-0.3%)
Mar 2010
-
$767.10 M(+2.1%)
Dec 2009
$751.40 M(+2.5%)
$751.40 M(+1.1%)
Sep 2009
-
$743.20 M(-3.3%)
Jun 2009
-
$768.70 M(+5.9%)
Mar 2009
-
$725.60 M(-1.0%)
Dec 2008
$732.80 M(+8.7%)
$732.80 M(+6.0%)
Sep 2008
-
$691.60 M(-11.6%)
Jun 2008
-
$782.50 M(+3.1%)
Mar 2008
-
$759.30 M(+12.6%)
Dec 2007
$674.30 M(+7.8%)
$674.30 M(+3.4%)
Sep 2007
-
$652.10 M(-5.5%)
Jun 2007
-
$689.70 M(-0.4%)
Mar 2007
-
$692.50 M(+10.7%)
Dec 2006
$625.50 M(+19.3%)
$625.50 M(+6.1%)
Sep 2006
-
$589.40 M(-7.8%)
Jun 2006
-
$639.20 M(+8.0%)
Mar 2006
-
$592.10 M(+13.0%)
Dec 2005
$524.20 M(-0.1%)
$524.20 M(-3.1%)
Sep 2005
-
$541.10 M(-5.6%)
Jun 2005
-
$573.40 M(+0.5%)
Mar 2005
-
$570.60 M(+8.7%)
Dec 2004
$524.80 M(+7.9%)
$524.80 M(+7.2%)
Sep 2004
-
$489.40 M(-7.9%)
Jun 2004
-
$531.10 M(+0.9%)
Mar 2004
-
$526.50 M(+8.2%)
Dec 2003
$486.40 M(+126.4%)
$486.40 M(+91.0%)
Sep 2003
-
$254.70 M(-1.7%)
Jun 2003
-
$259.10 M(+9.1%)
Mar 2003
-
$237.40 M(+10.5%)
Dec 2002
$214.80 M(+18.2%)
$214.80 M(+4.9%)
Sep 2002
-
$204.70 M(-6.5%)
Jun 2002
-
$218.90 M(+11.6%)
Mar 2002
-
$196.20 M(+8.0%)
Dec 2001
$181.70 M(-3.7%)
$181.70 M(-4.9%)
Sep 2001
-
$191.10 M
Dec 2000
$188.70 M
-

FAQ

  • What is Zimmer Biomet Holdings annual accounts receivable?
  • What is the all time high annual accounts receivable for Zimmer Biomet Holdings?
  • What is Zimmer Biomet Holdings annual accounts receivable year-on-year change?
  • What is Zimmer Biomet Holdings quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Zimmer Biomet Holdings?
  • What is Zimmer Biomet Holdings quarterly accounts receivable year-on-year change?

What is Zimmer Biomet Holdings annual accounts receivable?

The current annual accounts receivable of ZBH is $1.44 B

What is the all time high annual accounts receivable for Zimmer Biomet Holdings?

Zimmer Biomet Holdings all-time high annual accounts receivable is $1.60 B

What is Zimmer Biomet Holdings annual accounts receivable year-on-year change?

Over the past year, ZBH annual accounts receivable has changed by +$60.90 M (+4.41%)

What is Zimmer Biomet Holdings quarterly accounts receivable?

The current quarterly accounts receivable of ZBH is $1.48 B

What is the all time high quarterly accounts receivable for Zimmer Biomet Holdings?

Zimmer Biomet Holdings all-time high quarterly accounts receivable is $1.60 B

What is Zimmer Biomet Holdings quarterly accounts receivable year-on-year change?

Over the past year, ZBH quarterly accounts receivable has changed by +$39.10 M (+2.71%)